ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2021

Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial.

Robert P Baughman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.